Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

November 14, 2018 Leave a comment

Evox Therapeutics, a leading exosome therapeutics company, a leading exosome therapeutics company, today announces that it has secured £655,000 in funding from Duchenne UK. The grant will be invested to support exploration of the Company’s exosome-based therapeutic platform to deliver ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Duchenne UK

Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

Post-doc Position Available – Cancer and Infectious Disease Biomarkers

NeuroDex receives MJFF grant to study blood test for Parkinson’s stratification based on extracellular vesicles

Beckman research to boost astronaut fitness on NASA’s mission to Mars

MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award

Extracellular vesicles – the next generation in gene therapy delivery

$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy